A patient on linezolid for MRSA pneumonia develops serotonin syndrome after starting an SSRI. Which mechanism explains this interaction?
- A Linezolid inhibits serotonin reuptake
- B Linezolid inhibits CYP2D6
- C Linezolid causes serotonin release
- D Linezolid is a reversible MAO-A inhibitor ✓
Correct answer: D. Linezolid is a reversible MAO-A inhibitor
Explanation
Linezolid is a weak, reversible monoamine oxidase D inhibitor. When combined with SSRIs, it increases synaptic serotonin, risking serotonin syndrome. It does not inhibit CYP2A6 or directly cause serotonin release. This interaction is a key safety concern with oxazolidinones.
Reference: Katzung: Basic & Clinical Pharmacology, 14th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.